Biotech Investors & VC Firms in Boston

73 firms in this list, with a median first check of $1M. 19 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
BR Broadview Ventures CCBKCDHL21 people	88🔒	Boston	US	Seed–Late Stage	—	+ Add to CRM
K2 K2 HealthVentures PSAAASDK22 people	88🔒	Boston	US	Series A–Late Stage	$10M – $100M	+ Add to CRM
MA MassChallenge Mexico CBAMBDCH29 people · Follows rounds	88🔒	Boston	US	Pre-Seed–Growth	—	+ Add to CRM
CU Cure Ventures LTAJAMBA23 people	88🔒	Boston	US	Pre-Seed–Series A	—	+ Add to CRM
J2 J2 Ventures AHJBCKMG15 people · Follows rounds	88🔒	Boston	US	Pre-Seed–Series A	—	+ Add to CRM
RE REMUS Capital KKJTSHCM12 people · Leads rounds	88🔒	Boston	US	Pre-Seed–Series B	$25K – $20M	+ Add to CRM
BI BIOSPRING PARTNERS JLMDSZBM22 people	88🔒	New York	US	Growth–Late Stage	—	+ Add to CRM
82 82VS EAMSVSCL20 people	88🔒	Boston	US	Pre-Seed–Seed	—	+ Add to CRM
TE Tectonic Ventures JLMRMWDT9 people · Leads rounds	88🔒	Boston	US	Pre-Seed–Series A	—	+ Add to CRM
FO Foreground Capital EBSOAZAP9 people · Leads rounds	88🔒	Boston	US	Pre-Seed–Series B	—	+ Add to CRM
IA Iaso Ventures WMJRMGMF12 people	88🔒	Cambridge	US	Seed–Series A	—	+ Add to CRM
AM AMR Action Fund HSMHJGBB13 people	88🔒	Boston	US	Seed–Series C	—	+ Add to CRM
MA Magnetic Ventures CAJSUEUE9 people · Leads rounds	88🔒	Boston	US	Seed–Series A	$1M – $6M	+ Add to CRM
BL Blindspot Ventures Management Co ADHB8 people	88🔒	Boston	US	Pre-Seed–Late Stage	—	+ Add to CRM
EX Excel Venture Management CWJERBSG8 people	88🔒	Boston	US	Seed–Late Stage	$1M – $5M	+ Add to CRM
IN Innospark Ventures DVDVMFML10 people · Leads rounds	88🔒	Boston	US	Pre-Seed–Series A	$2M	+ Add to CRM
SU SustainVC SLACECJD6 people · Follows rounds	88🔒	Boston	US	Seed–Series A	$500K – $1M	+ Add to CRM
OM Omega Funds FDMPVOAM17 people	88🔒	Boston	US	Seed–Late Stage	—	+ Add to CRM
SO Solasta Ventures MJCCBCDY8 people	88🔒	Boston	US	Seed–Series C	—	+ Add to CRM
AP APERTURE Venture Partners ANESPTTC4 people	88🔒	Boston	US	Seed–Series C	$1M – $5M	+ Add to CRM
FI Fine Structures Ventures SKAJCDDN9 people	88🔒	Cambridge	US	Pre-Seed–Late Stage	—	+ Add to CRM
SP SpringTide Ventures AWCEBORM8 people · Leads rounds	88🔒	Boston	US	Seed–Series B	$500K – $5M	+ Add to CRM
MV MVM Life Science Partners EBEFHHJT11 people	88🔒	London	GB	Seed–Late Stage	$20M – $100M	+ Add to CRM
OR Orbia Ventures EDSAMJMO6 people	88🔒	Boston	US	Seed–Growth	$1M – $6M	+ Add to CRM

Broadview Ventures

BostonSeed–Late Stage

CCBKCDHL21 people

K2 HealthVentures

BostonSeries A–Late Stage$10M – $100M

PSAAASDK22 people

MassChallenge Mexico

BostonPre-Seed–Growth

CBAMBDCH29 people

Cure Ventures

BostonPre-Seed–Series A

LTAJAMBA23 people

J2 Ventures

BostonPre-Seed–Series A

AHJBCKMG15 people

REMUS Capital

BostonPre-Seed–Series B$25K – $20M

KKJTSHCM12 people

BIOSPRING PARTNERS

New YorkGrowth–Late Stage

JLMDSZBM22 people

82VS

BostonPre-Seed–Seed

EAMSVSCL20 people

Tectonic Ventures

BostonPre-Seed–Series A

JLMRMWDT9 people

Foreground Capital

BostonPre-Seed–Series B

EBSOAZAP9 people

Iaso Ventures

CambridgeSeed–Series A

WMJRMGMF12 people

AMR Action Fund

BostonSeed–Series C

HSMHJGBB13 people

Magnetic Ventures

BostonSeed–Series A$1M – $6M

CAJSUEUE9 people

Blindspot Ventures Management Co

BostonPre-Seed–Late Stage

ADHB8 people

Excel Venture Management

BostonSeed–Late Stage$1M – $5M

CWJERBSG8 people

Innospark Ventures

BostonPre-Seed–Series A$2M

DVDVMFML10 people

SustainVC

BostonSeed–Series A$500K – $1M

SLACECJD6 people

Omega Funds

BostonSeed–Late Stage

FDMPVOAM17 people

Solasta Ventures

BostonSeed–Series C

MJCCBCDY8 people

APERTURE Venture Partners

BostonSeed–Series C$1M – $5M

ANESPTTC4 people

Fine Structures Ventures

CambridgePre-Seed–Late Stage

SKAJCDDN9 people

SpringTide Ventures

BostonSeed–Series B$500K – $5M

AWCEBORM8 people

MVM Life Science Partners

LondonSeed–Late Stage$20M – $100M

EBEFHHJT11 people

Orbia Ventures

BostonSeed–Growth$1M – $6M

EDSAMJMO6 people

Data sourced from public filings and firms' own websites — see our methodology.